CHINA SXT PHARMACEUTICALS IN's ticker is SXTC and the CUSIP is G2161P108. A total of 9 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $218,000 | +190.7% | 664,647 | +118.2% | 0.00% | – |
| Q3 2020 | $75,000 | -84.7% | 304,674 | -67.2% | 0.00% | – |
| Q2 2020 | $490,000 | +46.3% | 929,408 | +55.2% | 0.00% | – |
| Q1 2020 | $335,000 | +129.5% | 598,741 | +235.2% | 0.00% | – |
| Q4 2019 | $146,000 | +484.0% | 178,601 | +806.6% | 0.00% | – |
| Q3 2019 | $25,000 | – | 19,701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudock, Inc. | 7,500 | $2,000 | 0.00% |
| UBS Group AG | 55,184 | $18,000 | 0.00% |
| FIFTH THIRD BANCORP | 1,000 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 106,568 | $35,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 36,886 | $12,000 | 0.00% |
| Renaissance Technologies | 664,647 | $218,000 | 0.00% |